Even in patients who have remission, primitive leukemia CD34+ stem/progenitor cells are still present, indicating that TKI therapy is not enough to cure CML [5,6]. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.